Relevant regulations on occupational exposure protection of anti-neoplastic drugs in China
10.3760/cma.j.cn121094-20231201-00137
- VernacularTitle:我国抗肿瘤药物职业暴露防护相关规定
- Author:
Yimu ZHENG
1
;
Shuqiang LI
;
Wei LIU
;
Li GUAN
Author Information
1. 北京大学第三医院职业病科，北京 100191
- Publication Type:Journal Article
- Keywords:
Antineoplastic drugs;
Health Hazard;
Occupational exposure;
Occupational Protection
- From:
Chinese Journal of Industrial Hygiene and Occupational Diseases
2025;43(4):309-312
- CountryChina
- Language:Chinese
-
Abstract:
Antineoplastic drugs have clear health hazards to the human body. In recent years, the scale of use of antineoplastic drugs had continued to expand, and the occupational exposure risk of medical personnel had also increased, which had attracted widespread attention. Taking effective measures to prevent occupational exposure can protect the health of medical personnel. This article reviewed the laws, regulations, guidelines, and industry guidance documents on occupational exposure prevention and control of antineoplastic drugs issued by relevant departments and associations in China. It summarized the scientific management experience of antineoplastic drugs in China, with the aim of reducing the occupational exposure risk of antineoplastic drugs in the future, and assisting the healthy development of China's medical and health industry.
